We have collected information about Durasite Drug Delivery Technology for you. Follow the links to find out details on Durasite Drug Delivery Technology.
https://www.businesswire.com/news/home/20120905005728/en/InSite-Vision-Introduces-DuraSite-2%C2%AE-Ophthalmic-Drug
Additionally, InSite will be finalizing and announcing a broad and novel licensing program with the intent of making DuraSite 2 a standard drug delivery technology in the ophthalmology industry ...
https://medical-dictionary.thefreedictionary.com/DuraSite
DuraSite: Ophthalmology A sustained-release system designed to permit the gradual release of a drug into the eye over a period of hrs, overcoming problems common with conventional drug delivery
https://drug-dev.com/insite-vision-introduces-durasite-2/
Additionally, InSite will be finalizing and announcing a broad and novel licensing program with the intent of making DuraSite 2 a standard drug delivery technology in the ophthalmology industry, and provide access to industry partners through both exclusive and non …
https://www.marketwatch.com/press-release/insite-vision-announces-patent-issuance-on-durasiter-2-ophthalmic-drug-delivery-system-2013-08-15
Aug 15, 2013 · Based on its ability to significantly improve drug retention and penetration into the tissues of the eye, we believe DuraSite 2 could serve as a standard drug delivery technology …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699985/
In eyedrop formulations with DuraSite, drug delivery can be sustained, with release from the matrix taking place over a period of up to 6 hours (Keller et al 1993; Harper et al 1995). Azithromycin in DuraSite is preserved with benzalkonium chloride. The formulation is sterile and stable for 9–12 months at room temperature.Author: Mitchell H Friedlaender, Eugene Protzko
https://www.siliconrepublic.com/start-ups/phion-therapeutics-drug-delivery
Oct 03, 2017 · Drug delivery builds on this formulation by helping the drug circulate in the body or extending the half-life of the drug. Delivery systems are now being designed that condense the …
https://www.marketwatch.com/press-release/insite-vision-receives-notice-of-allowance-from-uspto-for-patent-on-durasiter-2-ophthalmic-drug-delivery-system-2013-07-02
Jul 02, 2013 · The DuraSite and DuraSite 2 drug delivery systems extend the duration of drug retention on the surface of the eye, thereby reducing the frequency of treatment and improving the efficacy of …
https://www.bloomberg.com/profile/company/INSV:US
InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and ...Employees: 21
https://www.aol.com/article/finance/2013/08/15/insite-vision-announces-patent-issuance-on-durasit/20696090/
Aug 15, 2013 · InSite Vision Announces Patent Issuance on DuraSite ® 2 Ophthalmic Drug Delivery System New Therapeutics Formulated in Novel Platform Technology Will Have Patent ...
Searching for Durasite Drug Delivery Technology?
You can just click the links above. The data is collected for you.
